57
14. Chertow GM, Raggi P, McCarthy JT, et al. The effects of sevelamer and calcium
acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in
hemodialysis patients. Am J Nephrol 2003;23:307-314.
15. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks
in chronic hemodialysis patients. Kidney Int 2000;58:353-62.
16. Criqui MH, Langer RD, Fronek A, et al. Mortality Over a Period of 10 Years in
Patients with Peripheral Arterial Disease. N Engl J Med 1992;326:381-6.
17. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn.
Adv Ren Repl Ther 1995;2:295–304.
18. Daugirdas JT. Chronic Hemodialysis Prescription: A Urea Kinetic Approach. In:
Daugirdas JT, Blake GB,Ing TS. Handbook of Dialysis. Fourth Ed. Wolters
Kluwer/Lippincot Williams & Wilks; 2006:146-169.
19. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification
in end-stage renal disease. Kidney Int 2001;60:472- 479.
20. de Vinuesa SG, Ortega M, Martinez P, et al. Subclinical peripheral arterial
disease in patients with chronic kidney disease: Prevalence and related risk
factors. Kidney Int 2005;67(Suppl 93s):S44–S47.
21. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in
non-insulin-dependent diabetes mellitus: a systematic overview of the literature.
Arch Intern Med 1997;157:1413–18.
22. do Carmo WB, Pinheiro HS, Bastos MG. Doença Arterial Obstrutiva de Membros
Inferiores em Pacientes com Doença Renal Crônica Pré-Dialítica. J Bras Nefrol
2007;29:127-134.
23. Donnelly R, Hinwood D, London NJ: Non-invasive methods of arterial and venous
assessment. BMJ 2000;320:698-701.
24. Eguchi M, Tsuchihashi K, Takizawa H, et al. Detection of cardiac calcinosis in
hemodialysis patients by whole-body scintigraphy with 99m-technetium methylene
diphosphonate. Am J Nephrol 2000;20:278–282.
25. Ehrlich JE, Rumberger JA. Detection and Clinical Management of Cardiovascular
Calcification in ESRD: A Review. Dial Transplant 2004; 33: 306- 313.
26. Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA. Screening for
Peripheral Arterial Disease: The Sensitivity, Specificity, and Predictive Value of
Noninvasive Test in a Defined Population. Am J Epidemiol 1994;140:526-34.
27. Fishbane S, Youn S, Flaster E, Adam G. Maesaka JK. Ankle-Arm Blood Pressure
Index as a Predictor of Mortality in Hemodialysis Patients. Am J Kidney Dis
1996;27:668-672.
28. Fishbane S, Youn S, Kowalski EJ, Frei GL. Ankle-Arm Blood Pressure Index as a
Marker for Atherosclerotic Vascular Diseases in Hemodialysis Patients. Am J
Kidney Dis 1995;25:34-39.
29. Foley RN, Parfrey PS, Sarnak M. Clincial epidemiology of cardiovascular disease
in chronic renal disease. Am J Kidney Dis 1998;32:112–119.
30. Fowkes FG. Edinburgh Artery Study. prevalence of asymptomatic and
symptomatic peripheral arterial disease in the general population. International
Journal of Epidemiology 1991;20:384-392.
31. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in
epidemiological surveys. Int J Epidemiol 1988;17:248–254.
32. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of
elevated serum PO
4
, Ca x PO
4
product, and parathyroid hormone with cardiac
mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12: 2131–
2138.